Indonesia approves China's Sinovac vaccine, says 65.3% effective in trial
Skip to main content
  • Home
  • Economy
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Splash
  • Features
  • Videos
  • Long Read
  • Games
  • Epaper
  • More
    • COVID-19
    • Bangladesh
    • Infograph
    • Interviews
    • Offbeat
    • Thoughts
    • Podcast
    • Quiz
    • Tech
    • Subscribe
    • Archive
    • Trial By Trivia
    • Magazine
    • Supplement
  • বাংলা
The Business Standard
SUNDAY, MAY 22, 2022
SUNDAY, MAY 22, 2022
  • Home
  • Economy
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Splash
  • Features
  • Videos
  • Long Read
  • Games
  • Epaper
  • More
    • COVID-19
    • Bangladesh
    • Infograph
    • Interviews
    • Offbeat
    • Thoughts
    • Podcast
    • Quiz
    • Tech
    • Subscribe
    • Archive
    • Trial By Trivia
    • Magazine
    • Supplement
  • বাংলা
Indonesia approves China's Sinovac vaccine, says 65.3% effective in trial

Coronavirus chronicle

Reuters
11 January, 2021, 03:45 pm
Last modified: 11 January, 2021, 03:48 pm

Related News

  • Covax calls for urgent action to close vaccine equity gap
  • Indonesia to lift palm oil export ban from Monday
  • Indonesia hopes new programme will help lower cooking oil prices
  • Indonesia to drop outdoor mask mandate as Covid-19 infections drop
  • Indonesian farmers protest against rising cost of palm oil export ban

Indonesia approves China's Sinovac vaccine, says 65.3% effective in trial

The authorisation came after interim data from a late-stage human trial in Indonesia showed the vaccine was 65.3% effective, Penny K. Lukito, who heads the country’s food and drugs regulator BPOM, said

Reuters
11 January, 2021, 03:45 pm
Last modified: 11 January, 2021, 03:48 pm
A signage of Sinovac Biotech Ltd is seen at the 2020 China International Fair for Trade in Services (CIFTIS), following the Covid-19 outbreak, in Beijing, China September 5, 2020. Photo:Reuters
A signage of Sinovac Biotech Ltd is seen at the 2020 China International Fair for Trade in Services (CIFTIS), following the Covid-19 outbreak, in Beijing, China September 5, 2020. Photo:Reuters

Indonesia's food and drug agency on Monday granted emergency use approval to a Covid-19 vaccine developed by China's Sinovac Biotech, making it the first country outside China to give the regulatory greenlight to the vaccine.

The authorisation came after interim data from a late-stage human trial in Indonesia showed the vaccine was 65.3% effective, Penny K. Lukito, who heads the country's food and drugs regulator BPOM, said.

"These results meet the requirements of the World Health Organisation of a minimum of efficacy of 50%," she said, noting trial results in Brazil and Turkey.

A Brazil-based trial showed last week that Sinovac's vaccine candidate is 78% effective while Turkish researchers said in December the vaccine showed 91.25% efficacy based on interim analysis.

Indonesia is struggling with the worst Covid-19 outbreak in Southeast Asia and authorities are relying on a vaccine to help alleviate dual health and economic crises ravaging the country.

It has reported 836,718 Covid-19 infections and 24,343 deaths.

Indonesia has received 3 million doses of Sinovac's vaccine, named CoronaVac, and is slated to receive some 122.5 million more that will come in bulks.

Top News

Indonesia / covid-19 vaccine / Sinovac Covid-19 Vaccine

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • VAT on sales of locally-produced APIs likely to go from FY23
    VAT on sales of locally-produced APIs likely to go from FY23
  • Project delays: The Sinohydro case
    Project delays: The Sinohydro case
  • Haji Salim surrenders before court, seeks conditional bail 
    Haji Salim surrenders before court, seeks conditional bail 

MOST VIEWED

  • A person in personal protective equipment (PPE) walks a dog at a resident community, as the second stage of a two-stage lockdown has been launched to curb the spread of the coronavirus disease (Covid-19) in Shanghai, China April 3, 2022. REUTERS/Aly Song
    Shanghai reopens some public transport, still on high Covid alert
  • Workers in protective suit spray disinfectant at a community, during the lockdown to curb the spread of the coronavirus disease (COVID-19) in Shanghai, China, April 5, 2022. REUTERS/Aly Song
    Dynamic zero-Covid approach: China's choice to safeguard lives, underpin growth
  • People wearing protective face masks walk on a street, following new cases of the coronavirus disease (Covid-19), in Shanghai, China August 25, 2021. REUTERS/Aly Song
    Shanghai district to require all shops to shut, residents to stay home
  • Photo: Courtesy
    Covax calls for urgent action to close vaccine equity gap
  • Photo: BSS/AFP
    Covax calls for urgent action to close vaccine equity gap
  • Photo: Collected
    Thousands of Covid-negative Beijing residents sent to quarantine

Related News

  • Covax calls for urgent action to close vaccine equity gap
  • Indonesia to lift palm oil export ban from Monday
  • Indonesia hopes new programme will help lower cooking oil prices
  • Indonesia to drop outdoor mask mandate as Covid-19 infections drop
  • Indonesian farmers protest against rising cost of palm oil export ban

Features

Illustration: TBS

How the ban on porn sites spawned a local cybersex industry

2h | Panorama
3 best affordable sunscreens for all

3 best affordable sunscreens for all

2h | Mode
Warah uses three types of khadi material: a sheer and light one, a medium count and a thicker one.

Warah: Embroidered with culture and womanhood

4h | Mode
Photo: Courtesy

Misfit Technologies: A Singaporean startup rooted firmly in Bangladesh

4h | Panorama

More Videos from TBS

CV or Resume: Which one to create for job application

CV or Resume: Which one to create for job application

4h | Videos
Wheat prices double in India

Wheat prices double in India

18h | Videos
Is Washington-Moscow agreement possible?

Is Washington-Moscow agreement possible?

18h | Videos
Pigeon exhibition for the first time in Gazipur

Pigeon exhibition for the first time in Gazipur

22h | Videos

Most Read

1
Tk100 for bike, Tk2,400 for bus to cross Padma Bridge
Bangladesh

Tk100 for bike, Tk2,400 for bus to cross Padma Bridge

2
A packet of US five-dollar bills is inspected at the Bureau of Engraving and Printing in Washington March 26, 2015. REUTERS/Gary Cameron
Banking

Dollar hits Tk100 mark in open market

3
The story of Bangladesh becoming a major bicycle exporter
Industry

The story of Bangladesh becoming a major bicycle exporter

4
PK Halder: How a scamster rose from humble beginnings to a Tk11,000cr empire
Crime

PK Halder: How a scamster rose from humble beginnings to a Tk11,000cr empire

5
BSEC launches probe against Abul Khayer Hero and allies
Stocks

BSEC launches probe against Abul Khayer Hero and allies

6
The reception is a volumetric box-shaped room that has two glass walls on both the front and back ends and the other two walls are adorned with interior plants, wood and aluminium screens. Photo: Noor-A-Alam
Habitat

The United House: Living and working inside nature

The Business Standard
Top
  • Home
  • Entertainment
  • Sports
  • About Us
  • Bangladesh
  • International
  • Privacy Policy
  • Comment Policy
  • Contact Us
  • Economy
  • Sitemap
  • RSS

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net

Copyright © 2022 THE BUSINESS STANDARD All rights reserved. Technical Partner: RSI Lab